Pyoderma gangrenosum of the orbit. | Canada Hyperbarics Skip to main content
Clinical Study Eye (London, England) 1993

Pyoderma gangrenosum of the orbit.

Newman WD, Frank HJ — Eye (London, England), 1993

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report detailing the progression and treatment of a patient with pyoderma gangrenosum affecting the orbit.

What They Found

They found that a single patient experienced severe orbital destruction and eye perforation due to pyoderma gangrenosum, unresponsive to conventional therapy. Following evisceration and pre- and post-operative hyperbaric oxygen therapy, the disease process ceased.

Canadian Relevance

There is no direct Canadian connection mentioned in the study metadata or abstract.

Study Limitations

The primary limitation is that this is a single case report, which limits the generalizability of its findings to a broader patient population.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Wound Care
Source Pubmed
PubMed ID 8325431
Year Published 1993
Journal Eye (London, England)
MeSH Terms Aged; Eye Diseases; Eye Evisceration; Female; Humans; Hyperbaric Oxygenation; Orbital Diseases; Pyoderma Gangrenosum; Tomography, X-Ray Computed

Cite This Study

Share

This study relates to Problem Wounds. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: April 2, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology